SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-21-020241
Filing Date
2021-08-16
Accepted
2021-08-16 17:03:16
Documents
54
Period of Report
2021-06-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm   iXBRL 10-Q 821402
2 ex31-1.htm EX-31.1 18959
3 ex31-2.htm EX-31.2 19066
4 ex32-1.htm EX-32.1 10459
  Complete submission text file 0001493152-21-020241.txt   4371414

Data Files

Seq Description Document Type Size
5 XBRL SCHEMA FILE ptix-20210630.xsd EX-101.SCH 34359
6 XBRL CALCULATION FILE ptix-20210630_cal.xml EX-101.CAL 41694
7 XBRL DEFINITION FILE ptix-20210630_def.xml EX-101.DEF 166909
8 XBRL LABEL FILE ptix-20210630_lab.xml EX-101.LAB 313141
9 XBRL PRESENTATION FILE ptix-20210630_pre.xml EX-101.PRE 250519
10 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 635118
Mailing Address 149 FIFTH AVENUE SUITE 500 NEW YORK NY 10010
Business Address 149 FIFTH AVENUE SUITE 500 NEW YORK NY 10010 (212) 994-8200
Protagenic Therapeutics, Inc.\new (Filer) CIK: 0001022899 (see all company filings)

IRS No.: 061390025 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-12555 | Film No.: 211179547
SIC: 7389 Services-Business Services, NEC